U.S. OTC Market Posts Solid Growth in 2011 Driven by Rx-to-OTC Switches and Marketing

Posted on March 13, 2012 by Laura Mahecha, Industry Manager - Healthcare

From 2010 to 2011, the U.S. OTC drug market posted a gain of 2.4% from $20.9 billion in 2010 to $21.4 billion in 2011 at the manufacturers’ level. The fastest growing categories include allergy relief products, which grew 16.3% in 2011 aided by the market launch of Rx-to-OTC switch brand Allegra (Sanofi-Aventis) and the strong [...]

Filed under: Healthcare | Tagged: , , , , , , , , , , , , , , , , , , , , , | Leave a Comment »

New Data Shows Plenty of Room for Innovators of All Sizes in OTC Market

Posted on December 7, 2010 by Laura Mahecha, Industry Manager - Healthcare

The over-the-counter drug market is heating up as consumers turn increasingly toward self-medication in an effort to minimize out-of-pocket healthcare costs. With increasing competition from private-label products, blockbuster switches, and somewhat unconventional entries into the OTC drug business, new data reveals that while innovation doesn’t necessarily equate to superb business performance, there is plenty of [...]

Filed under: Healthcare | Tagged: , , , | Leave a Comment »

Prominent OTC companies on hand at CHPA’s Market Exchange

Posted on October 25, 2010 by Laura Mahecha, Industry Manager - Healthcare

Over-the-counter (OTC) medicines and                                                                        nutritional supplements play an increasingly vital role in America’s healthcare system. Sales continue to grow in spite of the recent recession, as customers seek cost-effective treatment options. Some OTC categories have even benefited from the economic downturn.

Filed under: Healthcare | Tagged: , , | Leave a Comment »

Branded OTC Product Recalls

Posted on October 1, 2010 by Laura Mahecha, Industry Manager - Healthcare

The largest OTC company, Johnson & Johnson’s McNeil Consumer Healthcare, has been plagued by a series of product recalls recently and this has widespread repercussions to the OTC industry. The problems have ranged from moldy odors and contaminated shipping palettes, to concerns about levels of active ingredients in products, and concerns about product safety and [...]

Filed under: Healthcare | Tagged: , | Leave a Comment »

OTC Industry Looks to High-Growth OTC Switches to Fuel Industry Growth

Posted on June 24, 2010 by Laura Mahecha, Industry Manager - Healthcare

Over the past few years, Rx-to-OTC switch products have emerged as a major growth driver in the U.S. OTC drug industry. While overall industry growth moderated to just 2.2% in 2008-2009, growth for Rx-to-OTC switches shot up by more than 12%. On the heels of numerous successful switches like Prevacid 24 Hour, Zegerid, Alli, and MiraLax, manufacturers have begun looking ahead at potential switch candidates much earlier in the Rx product life cycle. And with good reason: while the OTC market as a whole is expected to gain with just a CAGR of 2.6% over the next five years, future switches are set to explode by nearly 75%, adding more than $1.5 billion in absolute dollars to the OTC market.

Filed under: Healthcare | Tagged: , , , , | Leave a Comment »

Bring your input to OTC Drugs: U.S. Competitor Cost Structures 2010

Posted on May 27, 2010 by Laura Mahecha, Industry Manager - Healthcare

Kline is  pleased to announce that our research has begun for the OTC Drugs: U.S. Competitor Cost Structures 2010 study. Our lead research analyst, Mr. Prashant Sharma, is currently in touch with suppliers, manufacturers, packaging companies, ad agencies, financial analysts, and OTC marketers to understand how their cost structures have changed recently. We would like your [...]

Filed under: Healthcare | Leave a Comment »

Brands Make A Comeback; OTC Market Resilient During Recession

Posted on April 27, 2010 by Laura Mahecha, Industry Manager - Healthcare

The U.S. OTC market is often a challenging market to make predictions about. There are so many instances where companies, brands, consumers, and even regulators buck trends that there are often reasons to look at things on a case-by case basis. However, when it came to predicting the impact the economic recession of 2008-2009 would [...]

Filed under: Healthcare | Tagged: | Leave a Comment »

Recent Recession Decidedly Influenced Cost Structures in the U.S. Personal Care Market

Posted on January 29, 2010 by Laura Mahecha, Industry Manager - Healthcare

Most of the leading personal care marketers were hit by higher costs of goods caused by the recent recession. While the high crude oil prices from the beginning of 2008 resulted in higher raw material, processing, packaging, and distribution costs, these normalized in the second half of 2008 and the first half of 2009. The [...]

Filed under: Consumer Products | Leave a Comment »

Future Growth of OTC Market Linked Closely to Rx-to-OTC Switch Activity

Posted on October 19, 2009 by Laura Mahecha, Industry Manager - Healthcare

The years 2008 and 2009 have posed considerable challenges for branded OTC marketers caused by global recession, price-conscious consumers, and strong competition from private labels. However, Rx-to-OTC switch remains a strong prospect for future growth of the industry.

Filed under: Healthcare | Tagged: | Leave a Comment »

Proposed regulations on Acetaminophen intended to keep consumers safe will result in substantial burden for manufacturers and could actually restrict consumer access to commonly used OTCs

Posted on August 10, 2009 by Laura Mahecha, Industry Manager - Healthcare

An FDA advisory committee is weighing in on the safety of OTC acetaminophen, the key active ingredient found in many OTC pain relievers, sleeping aids, and cough and cold medications. The proposed regulations suggest either cutting down dosages of acetaminophen or completely pulling combination drugs that contain acetaminophen off the shelves.

Filed under: Healthcare | Tagged: | 1 Comment »

Next Page »
Follow

Get every new post delivered to your Inbox.

Join 346 other followers